Broste has today signed an agreement with the Danish company Propharma A/S, to become exclusive distributor for Propolis extracts on the European market.
Propharma A/S was founded in 1974 and is a modern medical company, developing, manufacturing and exporting Generic Pharmaceuticals. The company has specialised in producing extracts from propolis and hold several patents on water extracted propolis (PWE-13).
PWE 13 has several benefits, it is; anti-bacterial, anti-viral, anti-inflammatory, immuno-stimulatiory, local anaesthetic, cell regenerative etc.
Propolis is already being used in food supplements, infant formulas, chewing gum, throat lonzenges, youghurts etc.
|
.jpg)
